Copyright
©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 111260
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.111260
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.111260
Table 1 Demographics by critical care primary, n (%)
| Intensivist staffing model | ||
| No | Yes | |
| Number patients | 376.0 | 3429.0 |
| Number of males | 209.0 | 2156.0 |
| Percent males | 55.6 | 62.9 |
| Mean age (years) | 68.1 | 65.8 |
| Age (SD, deviation) | 13.9 | 12.9 |
| Mean weight (kg) | 90.5 | 88.8 |
| Weight (SD, deviation) | 27.3 | 24.1 |
| Charlson comorbidity index (mean ± SD) | 6.0 | 5.6 |
| Charlson comorbidity index (SD, deviation) | 2.8 | 2.8 |
| Sofa score (mean ± SD) | 7.9 | 6.8 |
| Sofa score (SD, deviation) | 2.5 | 2.6 |
| Hospital mortality | 26.1 | 13.2 |
| Hospital diagnoses | ||
| Acute respiratory failure | 217 (58) | 883 (26) |
| Sepsis | 194 (52) | 660 (19) |
| Septic shock | 137 (36) | 471 (14) |
| Pneumonia | 130 (35) | 549 (16) |
| Cardiac arrest | 44 (12) | 322 (9) |
| Unspecified shock | 42 (11) | 214 (6) |
| COVID-19 pneumonia | 40 (11) | 130 (4) |
| Viral pneumonia | 38 (10) | 109 (3) |
| Alcohol withdrawal | 35 (9) | 136 (4) |
| Cardiogenic shock | 22 (6) | 233 (7) |
| Hypovolemic shock | 21 (6) | 70 (2) |
| ARDS | 18 (5) | 110 (3) |
| Seizure | 18 (5) | 88 (3) |
| Status epilepticus | 2 (1) | 47 (1) |
Table 2 Discharged deceased and midazolam use, n (%)
Table 3 Critical care medicine primary and midazolam use
Table 4 Teaching intensive care unit and midazolam use
Table 5 Multivariate analysis on demographics and risk factors associated with the use of continuous midazolam infusion
| Predictors | OR | 95%CI (lower limit, upper limit) | P value |
| Age > 65 years | 0.43 | 0.31, 0.59 | < 0.0001 |
| Teaching ICU | 0.31 | 0.23, 0.42 | < 0.0001 |
| CCM primary | 0.11 | 0.08, 0.16 | < 0.0001 |
| Charlson score > 5 | 0.94 | 0.69, 1.29 | 0.7151 |
| SOFA score > 7 | 1.74 | 1.30, 2.33 | 0.0002 |
| Acute respiratory failure | 2.11 | 1.51, 2.94 | < 0.0001 |
| ARDS | 6.95 | 3.82, 12.64 | < 0.0001 |
| Cardiogenic shock | 3.01 | 1.95, 4.64 | < 0.0001 |
| Septic shock | 0.80 | 0.51, 1.25 | 0.3324 |
| Sepsis | 1.22 | 0.79, 1.88 | 0.3714 |
| Hypovolemic shock | 1.05 | 0.52, 2.12 | 0.8912 |
| Unspecified shock | 1.51 | 1.00, 2.28 | 0.0504 |
| Cardiac arrest | 1.38 | 0.94, 2.02 | 0.1034 |
| Pneumonia (bacterial) | 1.56 | 1.14, 2.14 | 0.005 |
| Viral pneumonia | 7.80 | 2.11, 28.80 | 0.0021 |
| COVID PNA | 0.41 | 0.11, 1.49 | 0.1742 |
| Seizure | 1.77 | 0.92, 3.42 | 0.0895 |
| Status epilepticus | 13.17 | 6.56, 26.45 | < 0.0001 |
| Alcohol withdrawal | 2.30 | 1.41, 3.74 | 0.0008 |
- Citation: Nestoiter KG, Feick K, Looney K, Zaccheo M, Wert Y, Franz C. Critical care primary services are associated with reduced midazolam use in the intensive care unit. World J Crit Care Med 2025; 14(4): 111260
- URL: https://www.wjgnet.com/2220-3141/full/v14/i4/111260.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.111260
